Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: Dosage requirements and pharmacokinetic studies

Gene D. Morse, Richard C. Reichman, Margaret A. Fischl, Michael Para, John Leedom, William Powderly, Lisa M. Demeter, Lionel Resnick, Yiannis Bassiakos, Joseph Timpone, Steve Cox, Donald Batts

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: Dosage requirements and pharmacokinetic studies'. Together they form a unique fingerprint.

Medicine & Life Sciences